NCT04865068

Brief Summary

Standards Echocardiographic have been defined mainly on caucasian or Asian populations. In the EchoNoRMAL study the criteria for African populations were based solely on data from 198 subjects. This study suggests the presence of different standards depending on the ethnic origin of the subjects. The aims of this study is to describe the proportion of subjects reclassified (normal-pathological) according to the use of echocardiographic norm differences showed in TAHES population (Sub Saharian Africans) with those routinely used

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 29, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

April 29, 2021

Status Verified

April 1, 2021

Enrollment Period

1.3 years

First QC Date

April 15, 2021

Last Update Submit

April 26, 2021

Conditions

Keywords

Echocardiography, Diagnosis

Outcome Measures

Primary Outcomes (1)

  • Proportion of subjects reclassified (from pathological to normal) according to the echocardiographic standard used (reference standard vs. TAHES standard).

    Compare the echocardiography standards previously established in TAHES study to those used routinely managed for the population of SSA migrants in la region New Aquitaine, in order to define pathological subjects

    18 months

Secondary Outcomes (1)

  • Describe the reasons of reclassification, based on the change of echocardiography standards use for the following criteria: left ventricular hypertrophy, left atrial dilatation, aortic dilatation, ascending, right ventricular dilatation

    18 months

Study Arms (1)

African migrant's population located in la region New Aquitaine.

EXPERIMENTAL

Echocardiography norms will be harvested data on SSA participants located in la region New Aquitaine, France

Diagnostic Test: Echocardiography measures on SSA participants

Interventions

Upon SSA Subject is admitted to the hospital for an echocardiography, * Information about this study process, * Participants will receive an information note ; * Administration of a medical history questionnaire, collection of cardiovascular risk factors, weight toe (all of which are routinely collected before an echocardiographic examination is performed); * Performing and recording the echocardiographic examination according to routine protocol * delivery of the results according to the usual management; * deferred analysis of the recordings on workstation with classification of the data (normal-pathological) according to the different standards

African migrant's population located in la region New Aquitaine.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- SSA Major Subjects (first generation or from or from first generation parents) admitted to the hospital for an echocardiography

You may not qualify if:

  • Participation refusal;
  • Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
  • Valvulopathy justifying an intervention;
  • Diseases of overload.
  • Any acute heart disease (endocarditis, myocarditis, coronary syndrome);
  • Valvulopathy justifying an intervention;
  • Diseases of overload.
  • Both participant and accompanying person unable to understand the information note written in French and in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren)

Limoges, 87000, France

Location

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Philippe Lacroix, Professor

    0033555056391

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Philippe Lacroix, Professor

CONTACT

Arnaud Garcia, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2021

First Posted

April 29, 2021

Study Start

June 1, 2021

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

April 29, 2021

Record last verified: 2021-04

Locations